Bilateral retinoblastoma: clinical presentation, management and treatment

被引:11
作者
Pichi, Francesco
Lembo, Andrea
De Luca, Mariacarla
Hadjistilianou, Theodora
Nucci, Paolo
机构
[1] San Giuseppe Hospital, University Eye Clinic, 20123 Milan
[2] Department of Ophthalmology, Azienda Ospedaliera, Universitaria Santa Maria Alle Scotte, Siena
关键词
HIGH-RISK FEATURES; FOCAL THERAPY; CHEMOREDUCTION; CHEMOTHERAPY; CLASSIFICATION; RADIOTHERAPY; RECURRENCE;
D O I
10.1007/s10792-012-9703-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Management of retinoblastoma (Rb), the most common intraocular malignant tumor in childhood, is tailored to each individual case and based on the overall situation. We present a case of bilateral Rbs in a 4-month-old girl, referred to our center for bilateral leukocoria. In the right eye, the optic disc was partially visible, and three large foci of retinoblastoma were noted adjective in the vitreous cavity with satellite retinal detachment. The macula was obscured by the tumors. The tumor was therefore classified as group D (International classification of retinoblastoma), and thus underwent intravenous chemotherapy with the standard three-agent protocol of ifosfamide, carboplatin and etoposide (ICE protocol) delivered monthly for six cycles, regressing with a type I calcified pattern. The left eye presented three multifocal yellow-white retinal masses, with a total retinal detachment, and secondary glaucoma. The lesions were classified as group E and, therefore, taking the results obtained by Shields et al. in group E tumors into consideration, underwent enucleation. This case clearly shows that this cancer is curable if detected at a stage in which it is still contained within the retina, subretinal space or vitreous, and that the management of Rb relies on an experienced team of ocular oncologists, pediatricians and pediatric ophthalmologists working together for the single goal of saving the child's life.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 26 条
  • [1] The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement
    Antoneli, Celia Beatriz Gianotti
    Ribeiro, Karina B.
    Rodrigue-Galindo, Carlos
    Soares, Fernando A.
    Arias, Victor A.
    Novaes, Paido E. R. S.
    Chojniak, Martha M.
    Malogolowkin, Marcio
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (10) : 700 - 704
  • [2] DEPOTTER P, 1994, J PEDIATR OPHTHALMOL, V31, P26
  • [3] Eagle RC, 2009, ARCH PATHOL LAB MED, V133, P1203, DOI 10.1043/1543-2165-133.8.1203
  • [4] Trends in the management of retinoblastoma: Evaluation of 1,196 consecutive eyes during 1974 to 2001
    Epstein, JA
    Shields, CL
    Shields, AA
    [J]. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2003, 40 (04) : 196 - 203
  • [5] Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy
    Gallie, BL
    Budning, A
    Deboer, G
    Thiessen, JJ
    Koren, G
    Verjee, Z
    Ling, V
    Chan, HSL
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (11) : 1321 - 1328
  • [6] Postenucleation adjuvant therapy in high-risk retinoblastoma
    Honavar, SG
    Singh, AD
    Shields, CL
    Meadows, AT
    Demirci, H
    Cater, J
    Shields, JA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (07) : 923 - 931
  • [7] Karcioglu ZA, 2005, ORBITAL TUMORS: DIAGNOSIS AND TREATMENT, P257, DOI 10.1007/0-387-27086-8_22
  • [8] Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma
    Kingston, JE
    Hungerford, JL
    Madreperla, SA
    Plowman, PN
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (11) : 1339 - 1343
  • [9] KNUDSON AG, 1974, AM J PATHOL, V77, P77
  • [10] Linn Murphree A, 2005, Ophthalmol Clin North Am, V18, P41